Understanding the mechanisms that regulate angiogenesis and translating these into effective therapies are of enormous scientific and clinical interests. In this report, we demonstrate the central role of CDP-diacylglycerol synthetase (CDS) in the regulation of VEGFA signaling and angiogenesis. CDS activity maintains phosphoinositide 4,5 bisphosphate (PIP2) availability through resynthesis of phosphoinositides, whereas VEGFA, mainly through phospholipase C␥1, consumes PIP2 for signal transduction. Loss of CDS2, 1 of 2 vertebrate CDS enzymes, results in vascular-specific defects in zebrafish in vivo and failure of VEGFA-induced angiogenesis in endothelial cells in vitro. Absence of CDS2 also results in reduced arterial differentiation and reduced angiogenic signaling. CDS2 deficitcaused phenotypes can be successfully rescued by artificial elevation of PIP2 levels, and excess PIP2 or increased CDS2 activity can promote excess angiogenesis. These results suggest that availability of CDScontrolled resynthesis of phosphoinositides is essential for angiogenesis. (Blood. 2012;120(2):489-498)
IntroductionAngiogenesis is a process that involves the growth of new blood vessels from preexisting vessels and is important during embryonic development and in many physiologic and pathologic conditions. 1,2 The complex process of angiogenesis, including endothelial cell proliferation, tip/stalk cell formation, migration, extracellular matrix remodeling, and lumen formation, is managed by angiogenic signaling networks. [3][4][5] Numerous proangiogenic and antiangiogenic factors have been identified, among which VEGF is a key mediator that promotes angiogenesis. In solid tumors, new blood vessels grow and infiltrate into the tumor, providing it with essential nutrients and oxygen and a route for tumor metastasis. Many types of tumors can produce massive amounts of VEGFA to promote their progression. Thus, antiangiogenesis, especially neutralizing VEGFA and blocking its signaling, has been regarded as a highly promising avenue for anticancer therapy. 6,7 VEGFA exerts its biologic effects by binding to and activating its receptors. VEGF receptor 2 (VEGFR2) is the main receptor that transduces VEGF-induced signaling in endothelial cells. Activation of VEGFR2 leads to phosphorylation of specific downstream signal transduction mediators, mainly phospholipase C ␥ (PLCG) and PI3K. Phosphoinositide 4,5 bisphosphate (PI4,5P2, PIP2) plays a key role in intracellular downstream transmission of VEGF-dependent signaling, serving as the proximal substrate for both major signaling arms. PI3K uses PIP2 to produce PI(3,4,5)P3, which activates Akt signaling, whereas PLC␥ hydrolyzes PIP2 to generate inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG), which further activate Ca 2ϩ metabolism, protein kinase C, NFAT, and ERK. Disruption of either of these 2 signaling arms causes defects in angiogenesis (supplemental Figure 1A, available on the Blood Web site; see the Supplemental Materials link at the top of the online article). 8,9 Breakdown a...